GO
Loading...

3M Net Profit Jumps on Sale of Pharma Business

Conglomerate 3M said Thursday its first-quarter earnings and revenue climbed from the same quarter last year, thanks to strength in its health care and security businesses and the sale of its European branded pharmaceutical business.

Dow component 3M reported net profit of $1.37 billion, or $1.85 a share, for the first quarter, up 52% from net profit of $899 million, or $1.17 a share, in the same quarter a year ago. Revenues rose 6.1% to $5.94 billion from $5.59 billion in the year-ago period.

Excluding the sale of the European drug business, the company earned $1.28 a share.

Looking ahead, the company said it expects full-year earnings per share of $4.50 to $4.85 as share, excluding one-time items. That’s in line with estimates from analysts polled by Thomson Financial, who were looking for $4.66 a share.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

Don't Miss

U.S. Video

  • CNBC's Michelle Caruso-Cabrera provides the latest on Saudi Arabia's oil production and its impact on the U.S. and Russia.

  • CNBC's Sara Eisen takes a looks at how consumer demand and innovation is driving big change in the beverage industry.

  • Both Oklahoma and Nebraska want to snuff out marijuana in Colorado because it isn't a legal drug as far as the Feds are concerned, reports CNBC's Kate Rogers.